Influence of hypoxia on tracer accumulation in squamous-cell carcinoma: In vitro evaluation for PET imaging

Nuclear Medicine and Biology

Volumn 23, Issue 8, 1996, Pages 941-946

  Minn, Heikki ^a,b   Clavo, Anaira C ^a,b   Wahl, Richard L ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

fluorodeoxyglucose; hypoxia; leucine; methionine; positron emission tomography; squamous cell carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE; LEUCINE; METHIONINE; METHYLMETHIONINE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; HYPOXIA; INTRAVENOUS DRUG ADMINISTRATION; POSITRON EMISSION TOMOGRAPHY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL SURVIVAL; DEOXYGLUCOSE; EVALUATION STUDIES; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LEUCINE; METHIONINE; OXYGEN; TOMOGRAPHY, EMISSION-COMPUTED; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0030294855     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(96)00134-5     Document Type: Article

References (35)

1. 1. Brown J. M. (1989) Keynote address: Hypoxic cell radiosensitizers: Where next? Int. J. Radiat. Oncol. Biol. Phys. 16, 987-993.
2. 2. Chapman J. D. (1991) Measurement of tumor hypoxia by invasive and non-invasive procedures - a review of recent clinical studies. Radiother. Oncol. 20 (Suppl 1), 13-19.
3. 3. Clavo A. C., Brown R. S. and Wahl R. L. (1995) 2-Fluoro-2-deoxy-D-glucose (FDG) uptake into human cancer cell lines is increased by hypoxia. J. Nucl. Med. 36, 1625-1632.
4. 4. Denekamp J. (1989) Physiological hypoxia and its influence on radiotherapy. In: The Biological Basis of Radiotherapy (Edited by Steel G. G., Adams G. E. and Horwich A.), pp. 115-134. Elsevier, Amsterdam.
5. 5. Greven K. M., Williams W. W., Keyes J. W., McGuirt W. F., Harkness B. A., Watson N. E. Jr., Raben M., Frazier L. C., Geisinger K. R. and Cappellari J. O. (1994) Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer. Int. J. Radiat. Oncol. Biol. Phys. 29, 841-845.
6. 6. Herholz K., Heindel W., Luyten P. R., denHollander J. A., Pietrzyk U., Voges J., Kugel H., Friedmann G. and Heiss W. D. (1992) In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann. Neurol. 31, 319-327.
7. 7. Higashi K., Clavo A. C. and Wahl R. L. (1993) Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J. Nucl. Med. 34, 414-419.
8. 8. Hockel M., Vorndran B., Schlenger K., Baussmann E. and Knapstein P. G. (1993) Tumor oxygenation: A new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol. Oncol. 51, 141-149.
9. 14C]tyrosine for the investigation of a kinetic model to measure protein synthesis rate with PET. J. Nucl. Med. 29, 524-529.
10. 10. Ishiwata K., Kubota K., Murakami M., Kubota R., Sasaki T., Ishi S. and Senda M. (1993) Re-evaluation of amino acid PET studies: Can the protein synthesis rates in brain and tumor tissues be measured in vivo? J. Nucl. Med. 34, 1936-1943.
11. 11. Jabour B. A., Choi Y., Hoh C. K., Rege S. D., Soong J. C., Lufkin R. B., Hanafee W. N., Maddahi J., Chaiken L., Bailet J., Phelps M. E., Hawkins R. A. and Abemeyer E. (1993) Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-dexoy-D-glucose and MR imaging correlation. Radiology 186, 27-35.
12. 12. Koh W. J., Rasey J. S., Evans M. L., Grierson J. R., Lewellen T. K., Graham M. M., Krohn K. A. and Griffin T. W. (1992) Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int. J. Radiat. Oncol. Biol. Phys. 22, 199-212.
13. 13. Koh W. J., Griffin T. W., Rasey J. S. and Laramore G. E. (1994) Positron emission tomography: A new tool for characterization of malignant disease and selection of therapy. Acta Oncol. 33, 323-327.
14. 14. Kubota K., Matsuzawa T., Takahashi T., Fujiwara T., Kinomura S., Ido T., Sato T., Kubota R., Tada M. and Ishiwata K. (1989) Rapid and sensitive response of carbon-11-L-methionine tumor uptake to irradiation. J. Nucl. Med. 30, 2012-2016.
15. 15. Kubota R., Kubota K., Yamada S., Tada M., Takahashi T., Iwata R. and Tamahashi N. (1995) Methionine uptake by tumor tissue: A microautoradiographic comparison with FDG. J. Nucl. Med. 36, 484-492.
16. 16. Lapela M., Grénman R., Kurki T., Joensuu H., Leskinen S., Lindholm P., Haaparanta M., Ruotsalainen U. and Minn H. (1995) FDG PET in detection of recurrence in head and neck cancer. Radiology 197, 205-211.
17. 17. Lartigau E., Le-Ridant A. M., Lambin P., Weeger P., Martin L., Sigal R., Lusinchi A., Luboinski B., Eschwege R and Guichard M. (1993) Oxygenation of head and neck tumors. Cancer 71, 2319-2325.
18. 11C]Methionine uptake in cancer PET studies. J. Comput. Assist. Tomogr. 16, 468-474.
19. 19. Lindholm P., Leskinen-Kallio S., Minn H., Bergman J., Haaparanta M., Lehikoinen P., Någren K., Ruotsalainen U., Teräs M. and Joensuu H. (1993) Comparison of fluorine-18 fluoro-deoxyglucose and carbon-11 methionine in head and neck cancer. J. Nucl. Med. 34, 1711-1716.
20. 11C]methionine. Int. J. Radiat. Oncol. Biol. Phys. 32, 789-794.
21. 21. Meyer G. J., van den Hoff J., Burchert W. and Hundeshagen H. (1993) Approaches to quantitative analysis of amino acid transport and metabolism. In: PET Studies on Amino Acid Metabolism and Protein Synthesis (Edited by Mazoyer B. M., Heiss W. D. and Comar D.), pp. 183-196. Kluwer Academic Publishers, Dordrecht.
22. 22. Minn H., Paul R. and Ahonen A. (1988) Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J. Nucl. Med. 29, 1521-1525.
23. 23. Molls M., Feldmann H. J. and Fuller J. (1994) Oxygenation of locally advanced recurrent rectal cancer, soft tissue sarcoma and breast cancer. Adv. Exp. Med. Biol. 345, 459-463.
24. 24. Overgaard J. and Horsman M. R. (1993) Overcoming hypoxic cell radioresistance. In: Basic Clinical Radiobiology (Edited by Steel G. G.), pp. 163-172. Edward Arnold, London.
25. 123I-iodoazomycin arabinoside: Preliminary report of a clinical study. Br. J. Cancer 65, 90-95.
26. 26. Passonneau, J. V. (1972) L-Lactate-Fluorometric method. In: Methods of Enzymatic Analysis (Edited by Bergmeyer H. U.), pp. 1468-1472, Academic Press, New York.
27. 27. Pekkola-Heino K., Kulmala J., Klemi P., Lakkala T., Aitasalo K., Joensuu H. and Grénman R. (1991) Effects of radiation fractionation on four squamous cell carcinoma lines with dissimilar inherent radiation sensitivity. J. Cancer Res. Clin. Oncol. 111, 597-602.
28. 28. Rasey J. S., Koh W., Grierson J. R., Grunbaum Z. and Krohn K. A. (1989) Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 17, 985-991.
29. 29. Rege S., Maass A., Chiaken L., Hoh C. K., Choi Y., Lufkin R., Anzai Y., Juillard G., Maddahi J. and Phelps M. E. (1994) Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 73, 3047-3058.
30. 30. Saunders M. I. (1994) Predictive testing of radiosensitivity in non-small cell carcinoma of the lung. Lung Cancer 10 (Suppl 1), 83S-90S.
31. 31. Shields A. F., Lim K., Grierson J., Link J. and Krohn K. A. (1990) Utilization of labeled thymidine uptake in DNA synthesis: Studies for PET. J. Nucl. Med. 31, 337-342.
32. 32. Wahl R. L., Henry C. A. and Ethier S. P. (1992) Serum glucose: Effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 183, 643-647.
33. 33. Wahl R. L. and Clavo A. C. (1993) Effects of hypoxia on cultured human tumor cell uptake of thymidine, L-methionine and FDG. J. Nucl. Med. 34 (Suppl), 73P.
34. 34. Yang D. J., Wallace S., Cherif A., Li C., Gretzer M. B., Kim E. E. and Podoloff D. A. (1995) Development of F-18 fluoroerythronitroimidazole as a new PET agent for imaging tumor hypoxia. Radiology 194, 795-800.
35. 35. Yeh S. H., Wu L. C., Liu R. S., Yang D. J., Yen S. H., Yu T. W., Chang C. W. and Chen K. Y. (1994) Fluorine-18 fluoromisonidazole ([F-18]-FMISO) tumor: Muscle retention ratio in detecting hypoxia in nasopharyngeal carcinoma. J. Nucl. Med. 35 (Suppl), 142P.